Letters
Neuraminidase inhibitors for influenza A and B
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7406.105-c (Published 10 July 2003) Cite this as: BMJ 2003;327:105
Antivirals need to be protected from adverse conditions to retain effectiveness
- Subhash C Arya, clinical microbiologist (subhashji@hotmail.com),
- Nirmala Agarwal, chief, obstetrics and gynaecology
- Sant Parmanand Hospital, 18 Alipore Road, Delhi 110054, India
EDITOR–Cooper et al outlined the role of neurominadase inhibitors in prophylaxis against and treatment of influenza.1 These agents would be important during the early phase of any outbreak of influenza. Nevertheless, their efficacy would be reduced if …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.